BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 15363652)

  • 1. Tumour eradication by antiangiogenic therapy: analysis and extensions of the model by Hahnfeldt et al. (1999).
    d'Onofrio A; Gandolfi A
    Math Biosci; 2004 Oct; 191(2):159-84. PubMed ID: 15363652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A family of models of angiogenesis and anti-angiogenesis anti-cancer therapy.
    D'Onofrio A; Gandolfi A
    Math Med Biol; 2009 Mar; 26(1):63-95. PubMed ID: 19033598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New approach to modeling of antiangiogenic treatment on the basis of Hahnfeldt et al. model.
    Poleszczuk J; Bodnar M; Foryś U
    Math Biosci Eng; 2011 Apr; 8(2):591-603. PubMed ID: 21631148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic targeting of the tumor vasculature.
    Tozer GM; Bicknell R
    Semin Radiat Oncol; 2004 Jul; 14(3):222-32. PubMed ID: 15254865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of angiogenesis inhibitors in tumour treatment.
    Fayette J; Soria JC; Armand JP
    Eur J Cancer; 2005 May; 41(8):1109-16. PubMed ID: 15911233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis.
    Ledzewicz U; Schättler H
    J Theor Biol; 2008 May; 252(2):295-312. PubMed ID: 18371982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor endothelial cells are targets for selective therapies: in vitro and in vivo models to evaluate antiangiogenic strategies.
    Dutour A; Rigaud M
    Anticancer Res; 2005; 25(6B):3799-807. PubMed ID: 16309166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Angiogenesis and antiangiogenic cancer therapy].
    Pour L; Hájek R; Buchler T; Maisnar V; Smolej L
    Vnitr Lek; 2004 Dec; 50(12):930-8. PubMed ID: 15717808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mathematical modelling of flow through vascular networks: implications for tumour-induced angiogenesis and chemotherapy strategies.
    McDougall SR; Anderson AR; Chaplain MA; Sherratt JA
    Bull Math Biol; 2002 Jul; 64(4):673-702. PubMed ID: 12216417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiangiogenic therapy at a crossroads: clinical trial results and future directions.
    Ellis LM
    J Clin Oncol; 2003 Dec; 21(23 Suppl):281s-283s. PubMed ID: 14645411
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rationale of antiangiogenic therapy].
    Tímár J; Paku S; Tóvári J; Döme B
    Magy Onkol; 2006; 50(2):141-51. PubMed ID: 16888678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges facing antiangiogenic therapy for cancer: impact of the tumor extracellular environment.
    Gagne P; Akalu A; Brooks PC
    Expert Rev Anticancer Ther; 2004 Feb; 4(1):129-40. PubMed ID: 14748663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
    Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms and therapeutic development of angiogenesis inhibitors.
    Cao Y
    Adv Cancer Res; 2008; 100():113-31. PubMed ID: 18620094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy of vascularised tumours: role of vessel density and the effect of vascular "pruning".
    d'Onofrio A; Gandolfi A
    J Theor Biol; 2010 May; 264(2):253-65. PubMed ID: 20100496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiangiogenic scheduling of lower dose cancer chemotherapy.
    Gately S; Kerbel R
    Cancer J; 2001; 7(5):427-36. PubMed ID: 11693902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Angiogenesis and endothelial cells in blood neoplasms].
    Usnarska-Zubkiewicz L; Poreba M; Kuliczkowski K
    Przegl Lek; 2006; 63(3):146-50. PubMed ID: 16969900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiangiogenic effects of zoledronate on cancer neovasculature.
    Metcalf S; Pandha HS; Morgan R
    Future Oncol; 2011 Nov; 7(11):1325-33. PubMed ID: 22044205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taking down tumors: vascular disrupting agents entering clinical trials.
    O'Hanlon LH
    J Natl Cancer Inst; 2005 Sep; 97(17):1244-5. PubMed ID: 16145041
    [No Abstract]   [Full Text] [Related]  

  • 20. The interaction of radiation therapy and antiangiogenic therapy.
    O'Reilly MS
    Cancer J; 2008; 14(4):207-13. PubMed ID: 18677126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.